Cullinan therapeutics to participate in fireside chat at stifel 2024 healthcare conference

Cambridge, mass., nov. 05, 2024 (globe newswire) -- cullinan therapeutics, inc. (nasdaq: cgem; “cullinan”), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced that nadim ahmed, chief executive officer, and jeffrey jones, m.d., m.b.a., chief medical officer, will participate in a fireside chat at the stifel 2024 healthcare conference, being held in new york on november 18 and 19, 2024.
CGEM Ratings Summary
CGEM Quant Ranking